Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Pacira BioSciences entered a definitive merger agreement with Viatris and a Viatris subsidiary. The subsidiary plans to launch a cash tender offer for all Pacira shares at $36.50 each, followed by a merger if conditions are met.
Pacira BioSciences will pay Viatris a $62 million termination fee under specified circumstances, per the reported agreement terms.